Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecruitment status updated to Completed with new sites added (Emory University; Sapporo and Sendai in Japan). The prior Active, not recruiting status and an older site entry were removed, and the revision was updated to v3.5.0.SummaryDifference0.4%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no visible changes to the study details or page content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this change appears to be a software/version update with no modifications to study data, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. This change does not appear to affect study details or user actions.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a Last Update Posted field and removed the Last Update Posted (Estimated) label from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedMinor version update on the page: Revision: v3.3.4 added and Revision: v3.3.3 removed. No study content, eligibility criteria, or user actions are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.